.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Moodys
Medtronic
US Department of Justice
Fish and Richardson
Healthtrust
McKesson
Accenture
Federal Trade Commission
Cerilliant

Generated: June 23, 2017

DrugPatentWatch Database Preview

Diethylpropion hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for diethylpropion hydrochloride and what is the scope of diethylpropion hydrochloride patent protection?

Diethylpropion hydrochloride
is the generic ingredient in five branded drugs marketed by Avanthi Inc, Sandoz, Actavis Labs Ut Inc, Epic Pharma Llc, Watson Labs, Teva, Ucb Inc, 3M, Tg United Labs, Sanofi Aventis Us, and Lannett Holdings Inc, and is included in sixteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for diethylpropion hydrochloride. Fifteen suppliers are listed for this compound.

Summary for Generic Name: diethylpropion hydrochloride

Tradenames:5
Patents:1
Applicants:11
NDAs:16
Drug Master File Entries: see list11
Suppliers / Packagers: see list15
Bulk Api Vendors: see list36
Clinical Trials: see list2,244
Patent Applications: see list7,319
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:diethylpropion hydrochloride at DailyMed

Pharmacology for Ingredient: diethylpropion hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Holdings Inc
DIETHYLPROPION HYDROCHLORIDE
diethylpropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL091680-001Oct 24, 2011ABRXNoNo► Subscribe► Subscribe
Sanofi Aventis Us
TENUATE
diethylpropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL017669-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Epic Pharma Llc
DIETHYLPROPION HYDROCHLORIDE
diethylpropion hydrochloride
TABLET;ORAL040828-001Nov 5, 2008DISCNNoNo► Subscribe► Subscribe
3m
TEPANIL
diethylpropion hydrochloride
TABLET;ORAL011673-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Avanthi Inc
DIETHYLPROPION HYDROCHLORIDE
diethylpropion hydrochloride
TABLET;ORAL201212-001Dec 22, 2010AARXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Fuji
Johnson and Johnson
McKinsey
US Department of Justice
Mallinckrodt
Federal Trade Commission
Cantor Fitzgerald
Covington
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot